Back to Results
First PageMeta Content
Pharmaceutical sciences / Johnson & Johnson / Synthes / DePuy / Food and Drug Administration / Levofloxacin / Medicine / Dow Jones Industrial Average / Pharmacology


Annual Report 2012 Caring for the world, one person at a time… inspires and unites the people of Johnson & Johnson.
Add to Reading List

Document Date: 2013-05-22 12:29:48


Open Document

File Size: 1,42 MB

Share Result on Facebook

Company

Johnson & Johnson Vision Care Inc. / Synthes Inc. / AmeriCares / Johnson & Johnson / Standard & Poor / Children / Johnson & Johnson Annual Report / Shanghai Elsker Mother & Baby Co. Ltd. / DePuy / Ethicon Endo-Surgery Inc. / Vascular Stent Systems / DePuy Synthes Companies / Biosense Webster Inc. / MEDICAL DEVICES AND DIAGNOSTICS / BabyCenter / /

Continent

Europe / /

Country

Bangladesh / South Africa / Russia / United States / China / /

Currency

USD / /

Event

FDA Phase / M&A / Dividend Issuance / Business Partnership / Natural Disaster / /

Facility

FDA’s Center / /

IndustryTerm

pharmaceutical treatment / oral care products / manufacturing suspension / skin care products / medical technology / electrophysiology products / launched products / pharmaceuticals / adequate mental health care services / treatment of metastatic castration-resistant disease / non-strategic products / treatment for HIV / power tools / DIABETES CARE / inadequate infrastructure / /

MedicalCondition

HIV / multiple myeloma / SKIN CARE INFECTION PREVENTION/OTHER / metastatic castration-resistant disease / severe plaque psoriasis / severely active rheumatoid arthritis / severe scoliosis / pulmonary embolism / severely active ulcerative colitis / pulmonary multi-drug-resistant tuberculosis / metastatic / castration-resistant prostate cancer / prostate cancer / immune-mediated inflammatory diseases / diabetic peripheral neuropathy / schizophrenia / bacterial infections / secondary acute myeloid leukemia / active ankylosing spondylitis / ovarian and other cancers / diabetes / pain / deep vein thrombosis / chronic disease / INFECTIOUS DISEASES / active psoriatic arthritis / chronic hepatitis C / /

MedicalTreatment

chemotherapy / first-aid / surgery / catheter / /

Organization

Medicines Control Council / American Red Cross / State Food and Drug Administration / European Medicines Agency / U.S. Food and Drug Administration / European Commission / Vistakon Division of Johnson & Johnson Vision Care / European Union / FDA’s Center for Devices and Radiological Health / /

Person

Asha / Jacqueline / James Burke / Alex Gorsky / Alexis / /

Position

Chairman / Board of Directors / and Chief Executive Officer / special items CHAIRMAN / leader in global health care / Chief Executive Officer / CEO / leader / CHAIRMAN / Major / /

Product

VELCADE / INVEGA / DOXIL / REMICADE / peginterferon / levofloxacin / PREZISTA / ribavirin / 800mg / doxorubicin hydrochloride / prednisone / LEVAQUIN / DACOGEN / EVARREST™ Fibrin Sealant Patch / PREZISTA® (darunavir) / SIRTURO™ (bedaquiline) tablets / Europe / ZYTIGA® (abiraterone acetate) / VELCADE® (bortezomib) / SIRTURO™ / XARELTO / STELARA® (ustekinumab) / ZYTIGA / SEDASYS® System / DACOGEN® (decitabine) / CONTROL® / XARELTO® (rivaroxaban) / NUCYNTA® ER / /

ProvinceOrState

New Jersey / Prince Edward Island / Johnson & Johnson / /

Technology

NEUROSCIENCE / sports medicine / cellular telephone / S.M.A.R.T. / laser / biomaterials / chemotherapy / genotype / /

URL

www.2012annualreport.jnj.com / /

SocialTag